Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2ng/ml strongly predict risk of amenorrhea in women with breast cancer (2022)
- Authors:
- Autor USP: BEDOSCHI, GIULIANO MARCHETTI - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.fertnstert.2022.08.652
- Subjects: MUTAÇÃO GENÉTICA; QUIMIOTERAPIA; AMENORREIA; NEOPLASIAS MAMÁRIAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2022
- Source:
- Título: Fertility and Sterility
- ISSN: 0015-0282
- Volume/Número/Paginação/Ano: v. 118, n. 4S, p.e231, res. P-291, 2022
- Conference titles: Scientific Congress of the American Society for Reproductive Medicine
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
OKTAY, Kutluk H. et al. Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2ng/ml strongly predict risk of amenorrhea in women with breast cancer. Fertility and Sterility. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.fertnstert.2022.08.652. Acesso em: 14 abr. 2026. , 2022 -
APA
Oktay, K. H., Turan, V., Bedoschi, G. M., Goldfarb, S. B., & Bang, H. (2022). Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2ng/ml strongly predict risk of amenorrhea in women with breast cancer. Fertility and Sterility. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.fertnstert.2022.08.652 -
NLM
Oktay KH, Turan V, Bedoschi GM, Goldfarb SB, Bang H. Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2ng/ml strongly predict risk of amenorrhea in women with breast cancer [Internet]. Fertility and Sterility. 2022 ; 118( 4S): e231.[citado 2026 abr. 14 ] Available from: https://doi.org/10.1016/j.fertnstert.2022.08.652 -
Vancouver
Oktay KH, Turan V, Bedoschi GM, Goldfarb SB, Bang H. Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2ng/ml strongly predict risk of amenorrhea in women with breast cancer [Internet]. Fertility and Sterility. 2022 ; 118( 4S): e231.[citado 2026 abr. 14 ] Available from: https://doi.org/10.1016/j.fertnstert.2022.08.652 - Ovarian transplantation with robotic surgery and a neovascularizing human extracellular matrix scaffold: a case series in comparison to meta-analytic data
- Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer
- Caracterização do impacto dos regimes quimioterápicos na reserva ovariana de pacientes com câncer de mama
- Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2ng/ml strongly predict risk of amenorrhea in women with breast cancer
- Feasibility and safety of combined laparoscopic and transvaginal oocyte retrieval in a woman with vaginal recurrence of cervical adenocarcinoma: a case report
- Fertility preservation and ovarian hyperstimulation syndrome management in cancer care: a pathophysiological perspective on gonadotropin-releasing hormone agonists and antagonists
- Oncofertility programs still suffer from insufficient resources in limited settings
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
